97 related articles for article (PubMed ID: 29741770)
21. PiwiRNA-651 as marker of treatment response and survival in classical Hodgkin lymphoma.
Cordeiro A; Navarro A; Gaya A; Díaz-Beyá M; Gonzalez-Farré B; Castellano JJ; Fuster D; Martínez C; Martínez A; Monzó M
Oncotarget; 2016 Jul; 7(29):46002-46013. PubMed ID: 27329591
[TBL] [Abstract][Full Text] [Related]
22. CTLA4 blockade elicits paraneoplastic neurological disease in a mouse model.
Yshii LM; Gebauer CM; Pignolet B; Mauré E; Quériault C; Pierau M; Saito H; Suzuki N; Brunner-Weinzierl M; Bauer J; Liblau R
Brain; 2016 Nov; 139(11):2923-2934. PubMed ID: 27604307
[TBL] [Abstract][Full Text] [Related]
23. Expression of Immune Checkpoint Receptors on T-Cells and Their Ligands on Leukemia Blasts in Childhood Acute Leukemia.
Kang SH; Hwang HJ; Yoo JW; Kim H; Choi ES; Hwang SH; Cho YU; Jang S; Park CJ; Im HJ; Seo JJ; Kim N; Koh KN
Anticancer Res; 2019 Oct; 39(10):5531-5539. PubMed ID: 31570447
[TBL] [Abstract][Full Text] [Related]
24. [Study on mRNA expression of immune-related genes in patients with allergic dermatitis induced by trichloroethylene].
Xu XY; Liu YF; Yi J; Ke YB; Yuan JH; Huang HY; Mao JY; Mao KL
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2011 Nov; 29(11):816-9. PubMed ID: 22357516
[TBL] [Abstract][Full Text] [Related]
25. CSF-1R expression in tumor-associated macrophages is associated with worse prognosis in classical Hodgkin lymphoma.
Koh YW; Park C; Yoon DH; Suh C; Huh J
Am J Clin Pathol; 2014 Apr; 141(4):573-83. PubMed ID: 24619759
[TBL] [Abstract][Full Text] [Related]
26. Flow cytometry for assessment of the tumor microenvironment in pediatric Hodgkin lymphoma.
Henry M; Buck S; Savaşan S
Pediatr Blood Cancer; 2018 Nov; 65(11):e27307. PubMed ID: 30009533
[TBL] [Abstract][Full Text] [Related]
27. Cytotoxic T- Lymphocyte Antigen-4 (CTLA4) Gene Expression and Urinary CTLA4 Levels in Idiopathic Nephrotic Syndrome.
Mishra OP; Chhabra P; Narayan G; Srivastava P; Prasad R; Singh A; Abhinay A; Batra VV
Indian J Pediatr; 2019 Jan; 86(1):26-31. PubMed ID: 29968132
[TBL] [Abstract][Full Text] [Related]
28. Rescue of Cytokine Storm Due to HLH by Hemoadsorption in a CTLA4-Deficient Patient.
Greil C; Roether F; La Rosée P; Grimbacher B; Duerschmied D; Warnatz K
J Clin Immunol; 2017 Apr; 37(3):273-276. PubMed ID: 28265964
[No Abstract] [Full Text] [Related]
29. Autoimmunity-mediated antitumor immunity: tumor as an immunoprivileged self.
Miska J; Bas E; Devarajan P; Chen Z
Eur J Immunol; 2012 Oct; 42(10):2584-96. PubMed ID: 22777737
[TBL] [Abstract][Full Text] [Related]
30. Hodgkin-like anaplastic large cell lymphoma (previously designated in the REAL classification) has same immunophenotypic features to classical Hodgkin lymphoma.
Tamaru J; Tokuhira M; Nittsu N; Nakamura S; Ichinohasama R; Suzuki R; Mori H; Takagi T; Suzuki T; Itami J; Itoyama S; Mikata A
Leuk Lymphoma; 2007 Jun; 48(6):1127-38. PubMed ID: 17577776
[TBL] [Abstract][Full Text] [Related]
31. Bone Marrow Involvement in Patients With Nodular Lymphocyte Predominant Hodgkin Lymphoma.
Agbay RLMC; Loghavi S; Zuo Z; Fayad L; Dabaja B; Medeiros LJ; Khoury JD
Am J Surg Pathol; 2018 Apr; 42(4):492-499. PubMed ID: 29309302
[TBL] [Abstract][Full Text] [Related]
32. Hodgkin lymphoma: pathology, pathogenesis, and a plethora of potential prognostic predictors.
King RL; Howard MT; Bagg A
Adv Anat Pathol; 2014 Jan; 21(1):12-25. PubMed ID: 24316907
[TBL] [Abstract][Full Text] [Related]
33. Prognostic impact of tumour-infiltrating Th2 and regulatory T cells in classical Hodgkin lymphoma.
Schreck S; Friebel D; Buettner M; Distel L; Grabenbauer G; Young LS; Niedobitek G
Hematol Oncol; 2009 Mar; 27(1):31-9. PubMed ID: 18924115
[TBL] [Abstract][Full Text] [Related]
34. Prognostic impact of CD15 expression and proliferative index in the outcome of children with classical Hodgkin lymphoma.
Barros MH; Zalcberg IR; Hassan R
Pediatr Blood Cancer; 2008 Feb; 50(2):428-9; author reply 430. PubMed ID: 17973313
[No Abstract] [Full Text] [Related]
35. Checkpoint blockade in lymphoma.
Armand P
Hematology Am Soc Hematol Educ Program; 2015; 2015():69-73. PubMed ID: 26637703
[TBL] [Abstract][Full Text] [Related]
36. Prospective Analysis of Adoptive TIL Therapy in Patients with Metastatic Melanoma: Response, Impact of Anti-CTLA4, and Biomarkers to Predict Clinical Outcome.
Forget MA; Haymaker C; Hess KR; Meng YJ; Creasy C; Karpinets T; Fulbright OJ; Roszik J; Woodman SE; Kim YU; Sakellariou-Thompson D; Bhatta A; Wahl A; Flores E; Thorsen ST; Tavera RJ; Ramachandran R; Gonzalez AM; Toth CL; Wardell S; Mansaray R; Patel V; Carpio DJ; Vaughn C; Farinas CM; Velasquez PG; Hwu WJ; Patel SP; Davies MA; Diab A; Glitza IC; Tawbi H; Wong MK; Cain S; Ross MI; Lee JE; Gershenwald JE; Lucci A; Royal R; Cormier JN; Wargo JA; Radvanyi LG; Torres-Cabala CA; Beroukhim R; Hwu P; Amaria RN; Bernatchez C
Clin Cancer Res; 2018 Sep; 24(18):4416-4428. PubMed ID: 29848573
[No Abstract] [Full Text] [Related]
37. Childhood Hodgkin International Prognostic Score (CHIPS) Predicts event-free survival in Hodgkin Lymphoma: A Report from the Children's Oncology Group.
Schwartz CL; Chen L; McCarten K; Wolden S; Constine LS; Hutchison RE; de Alarcon PA; Keller FG; Kelly KM; Trippet TA; Voss SD; Friedman DL
Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27786406
[TBL] [Abstract][Full Text] [Related]
38. Rare presentation of classical Hodgkin lymphoma with a clonal T-cell receptor gene rearrangement in the tissue.
Nguyen TT; Warnke RA; Seo K; Rosenberg SA; Arber DA
Leuk Lymphoma; 2010 Jul; 51(7):1356-9. PubMed ID: 20496992
[No Abstract] [Full Text] [Related]
39. The ratio of FOXP3+ regulatory T cells to granzyme B+ cytotoxic T/NK cells predicts prognosis in classical Hodgkin lymphoma and is independent of bcl-2 and MAL expression.
Kelley TW; Pohlman B; Elson P; Hsi ED
Am J Clin Pathol; 2007 Dec; 128(6):958-65. PubMed ID: 18024321
[TBL] [Abstract][Full Text] [Related]
40. Classical Hodgkin Lymphoma with Reduced β2M/MHC Class I Expression Is Associated with Inferior Outcome Independent of 9p24.1 Status.
Roemer MG; Advani RH; Redd RA; Pinkus GS; Natkunam Y; Ligon AH; Connelly CF; Pak CJ; Carey CD; Daadi SE; Chapuy B; de Jong D; Hoppe RT; Neuberg DS; Shipp MA; Rodig SJ
Cancer Immunol Res; 2016 Nov; 4(11):910-916. PubMed ID: 27737878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
